1

BioSig Technologies

#9091

Rank

$117.95M

Marketcap

US United States

Country

BioSig Technologies
Leadership team

Mr. Kenneth L. Londoner M.B.A., MBA (Founder, CEO & Exec. Chairman)

Mr. John Sieckhaus (Chief Operating Officer)

Mr. Steven Chaussy CPA (Chief Financial Officer)

Products/ Services
Biotechnology, Health Care, Medical Device
Headquarters
Westport, Connecticut, United States
Established
2009
Company Registration
SEC CIK number: 0001530766
Traded as
BSGM
Social Media
Overview
Location
Summary
BioSig Technologies, Inc., together with its subsidiaries, operates as medical device company. The company's proprietary product includes precise uninterrupted real-time evaluation of electrograms electrophysiology (PURE EP) system, a signal processing platform that combines hardware and software to address known challenges associated to signal acquisition that enables electrophysiologists to see signals and analyze in real-time. It also focuses on enhancing intracardiac signal acquisition and diagnostic information for the procedures of atrial fibrillation, as well as is designed to address long-standing limitations that slow and disrupt cardiac catheter ablation procedures. The company has a research agreement with University of Minnesota to develop novel therapies to treat sympathetic nervous system diseases; and a strategic collaboration with the Mayo Foundation for Medical Education and Research to develop an AI-and machine learning software solution for PURE EP systems. BioSig Technologies, Inc. was incorporated in 2009 and is headquartered in Westport, Connecticut.
History

Founded in 2008, BioSig Technologies has secured multiple clinical, safety, and regulatory milestones to support the adoption of its PURE EP System technology. They have five approved U.S. patents and several patents pending.

Mission
BioSig Technologies’ mission is to improve the treatment of arrhythmia and related disorders with proprietary signal processing technology.
Vision
BioSig’s vision is to become the preeminent signal processing company for the acquisition and analysis of cardiac arrhythmias and related disorders.
Key Team

Dr. Budimir S. Drakulic Ph.D. (Chief Scientist)

Ms. Brenda Castrodad (VP of HR)

Mr. Andrew Gornell Ballou (VP of Investor Relations)

Mr. Gray Fleming Jr. (Chief Commercial Officer)

Recognition and Awards
BioSig technologies has been awarded various honors and recognitions for their efforts, such as being selected for the MD+DI Innovators Award in 2017 and the Deloitte Technology Fast 500 Award in 2018.
References

Dive deeper into fresh insights across Business, Industry Leaders and Influencers, Organizations, Education, and Investors for a comprehensive view.

BioSig Technologies
Leadership team

Mr. Kenneth L. Londoner M.B.A., MBA (Founder, CEO & Exec. Chairman)

Mr. John Sieckhaus (Chief Operating Officer)

Mr. Steven Chaussy CPA (Chief Financial Officer)

Products/ Services
Biotechnology, Health Care, Medical Device
Headquarters
Westport, Connecticut, United States
Established
2009
Company Registration
SEC CIK number: 0001530766
Traded as
BSGM
Social Media